Total Payments
$4,163
2024 Payments
$1,080
Companies
22
Transactions
103
Medicare Patients
1,387
Medicare Billing
$161,639
Payment Breakdown by Category
Food & Beverage$2,566 (61.6%)
Travel$1,377 (33.1%)
Education$220.13 (5.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,566 | 96 | 61.6% |
| Travel and Lodging | $1,377 | 5 | 33.1% |
| Education | $220.13 | 2 | 5.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $2,257 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $255.89 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $217.16 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $169.85 | 8 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $156.40 | 4 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $147.47 | 8 | $0 (2024) |
| Kiniksa Pharmaceuticals International, plc | $139.72 | 6 | $0 (2024) |
| Merck Sharp & Dohme LLC | $132.54 | 8 | $0 (2024) |
| Novo Nordisk Inc | $110.85 | 2 | $0 (2024) |
| Amgen Inc. | $78.07 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,080 | 42 | Novartis Pharmaceuticals Corporation ($171.99) |
| 2023 | $802.49 | 37 | Janssen Pharmaceuticals, Inc ($187.02) |
| 2022 | $2,280 | 24 | Abbott Laboratories ($2,138) |
All Payment Transactions
103 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Cardiology | ||||||
| 11/21/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: Not Applicable | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $24.15 | General |
| 11/20/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $6.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.75 | General |
| 10/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $0.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/19/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: General - Therapies_CRM | ||||||
| 06/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/30/2024 | MEDICOMP INC | TELEPATCH CARDIAC MONITOR (Device) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: CARDIOLOGY | ||||||
| 05/29/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: Not Applicable | ||||||
| 05/24/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.39 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.48 | General |
| 05/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/26/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Not Applicable | ||||||
| 04/25/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Education | In-kind items and services | $84.99 | General |
| Category: Cardiology | ||||||
| 04/25/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Cardiology | ||||||
| 04/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Cardio-renal | ||||||
| 04/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.52 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,166 | 1,434 | $516,912 | $136,551 |
| 2022 | 6 | 221 | 269 | $133,962 | $25,088 |
Total Patients
1,387
Total Services
1,703
Medicare Billing
$161,639
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 165 | 288 | $86,183 | $30,645 | 35.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 121 | 125 | $129,875 | $21,483 | 16.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 42 | 42 | $48,888 | $17,188 | 35.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 113 | 113 | $43,842 | $14,545 | 33.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 63 | 75 | $18,997 | $7,550 | 39.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 112 | 114 | $53,390 | $6,616 | 12.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 45 | 45 | $18,006 | $6,478 | 36.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 50 | 50 | $14,728 | $5,668 | 38.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $13,297 | $4,938 | 37.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 47 | 70 | $12,219 | $4,751 | 38.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 20 | 80 | $8,000 | $3,296 | 41.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 20 | $8,112 | $3,049 | 37.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 47 | 47 | $17,202 | $2,609 | 15.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 169 | 204 | $10,200 | $2,485 | 24.4% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 15 | 17 | $6,064 | $1,547 | 25.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 12 | $3,186 | $1,019 | 32.0% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 42 | 42 | $12,012 | $980.99 | 8.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 11 | 11 | $8,611 | $720.17 | 8.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 13 | $2,762 | $677.64 | 24.5% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 14 | 16 | $872.00 | $242.88 | 27.9% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 22 | 24 | $466.66 | $62.64 | 13.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 34 | 74 | $17,056 | $6,630 | 38.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 25 | 28 | $12,522 | $4,859 | 38.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 23 | 23 | $23,897 | $4,166 | 17.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 61 | 61 | $63,379 | $3,717 | 5.9% |
About Dr. Maranatha Gabaud, MD
Dr. Maranatha Gabaud, MD is a Cardiovascular Disease healthcare provider based in Silver Spring, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2016. The National Provider Identifier (NPI) number assigned to this provider is 1275988701.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maranatha Gabaud, MD has received a total of $4,163 in payments from pharmaceutical and medical device companies, with $1,080 received in 2024. These payments were reported across 103 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,566).
As a Medicare-enrolled provider, Gabaud has provided services to 1,387 Medicare beneficiaries, totaling 1,703 services with total Medicare billing of $161,639. Data is available for 2 years (2022–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Silver Spring, MD
- Active Since 05/03/2016
- Last Updated 08/01/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1275988701
Products in Payments
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $1,926
- XARELTO (Drug) $217.16
- ENSITE PRECISION (Device) $211.70
- LEQVIO (Drug) $178.98
- LifeVest (Device) $147.47
- Arcalyst (Drug) $139.72
- OPSUMIT (Drug) $134.59
- VERQUVO (Drug) $132.54
- AVEIR (Device) $119.25
- Repatha (Biological) $78.07
- ENTRESTO (Drug) $76.91
- TELEPATCH CARDIAC MONITOR (Device) $70.55
- Inpefa (Drug) $58.48
- ELIQUIS (Drug) $49.90
- VYNDAQEL (Drug) $46.19
- INSPIRE (Device) $41.84
- JARDIANCE (Drug) $41.56
- (5044) MCOT (Device) $39.48
- Rybelsus (Drug) $23.12
- BRILINTA (Drug) $22.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Silver Spring
Dr. Homam Ibrahim, Md, MD
Cardiovascular Disease — Payments: $57,296
Cardiovascular Disease $57,296
Dr. Michael Lincoln, M.d, M.D
Cardiovascular Disease — Payments: $25,323
Cardiovascular Disease $25,323
Ellis Unger, M.d, M.D
Cardiovascular Disease — Payments: $22,500
Cardiovascular Disease $22,500
Stephen Grant, M.d, M.D
Cardiovascular Disease — Payments: $13,210
Cardiovascular Disease $13,210
Dr. Eric Lieberman, M.d, M.D
Cardiovascular Disease — Payments: $8,636
Cardiovascular Disease $8,636
Srivasavi Chaganti, M.d, M.D
Cardiovascular Disease — Payments: $5,728
Cardiovascular Disease $5,728